EW
$84.27
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally.
Intraday
Recent News
Should You Continue to Hold Bio-Techne Stock in Your Portfolio?
TECH expands via acquisitions and global growth, but biotech funding softness, U.S. academic spending pressure and competition cloud near-term outlook.
Edwards Lifesciences (EW) Valuation Check After Recent Share Price Momentum
What Edwards Lifesciences stock’s recent move might be telling you Edwards Lifesciences (EW) has attracted attention after a 2.1% daily gain, set against mixed recent returns including a roughly 10.1% rise over the past month and a small decline over the past 3 months. See our latest analysis for Edwards Lifesciences. At a share price of $83.56, Edwards Lifesciences pairs a 10.1% 1 month share price return with a 2.1% year to date decline, while its 1 year total shareholder return sits at...
Should You Continue to Hold Integra Stock in Your Portfolio Now?
IART faces macro headwinds and tight liquidity, but strong demand in its Codman Specialty Surgical unit and expanding international launches could support growth.
This Investor Sold $5 Million of a Biotech Stock Up 118% in a Year, but Here's Why It Still Seems Bullish on Shares
This biotech firm develops therapies targeting cystic fibrosis, with shares up nearly 90% year-over-year as of the latest filing.
This Investor Built a $56 Million Position in RAPT Last Quarter. It Was Just Acquired for $58 Per Share
RAPT Therapeutics develops oral therapies for cancer and inflammation, with key drug candidates currently in clinical trials.